+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rosuvastatin"

Cardiovascular Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cardiovascular Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Cholesterol Lowering Drug Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cholesterol Lowering Drug Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
Statins Market - Global Forecast 2025-2032 - Product Thumbnail Image

Statins Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Atherosclerosis Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Atherosclerosis Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 196 Pages
  • Global
From
Hypercholesterolemia Drug Market - Global Forecast 2025-2032 - Product Thumbnail Image

Hypercholesterolemia Drug Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 181 Pages
  • Global
From
From
Statins - Global Strategic Business Report - Product Thumbnail Image

Statins - Global Strategic Business Report

  • Report
  • October 2025
  • 192 Pages
  • Global
From
Hyperlipidemia Drugs Market Report 2025 - Product Thumbnail Image

Hyperlipidemia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Angina Pectoris Drugs Market Report 2025 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Artery Stenosis Drug Market Report 2025 - Product Thumbnail Image

Artery Stenosis Drug Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Dyslipidemia Market Report 2025 - Product Thumbnail Image

Dyslipidemia Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
ACE/ARB Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACE/ARB Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hypercholesterolemia Global Market Report 2025 - Product Thumbnail Image

Hypercholesterolemia Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Statin Market Report by Type, and Region 2025-2033 - Product Thumbnail Image

Statin Market Report by Type, and Region 2025-2033

  • Report
  • August 2025
  • 143 Pages
  • Global
From
From
Atherosclerosis Pipeline Analysis Report 2025 - Product Thumbnail Image

Atherosclerosis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Investigation Report on China's Rosuvastatin Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Rosuvastatin Market, 2018-2022

  • Report
  • November 2018
  • 30 Pages
  • China
From
Loading Indicator

Rosuvastatin is a drug used to treat high cholesterol and other lipid disorders. It belongs to a class of drugs known as statins, which work by blocking an enzyme in the liver that is responsible for producing cholesterol. Rosuvastatin is used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high cholesterol levels. It is also used to reduce the risk of cardiovascular events in people with type 2 diabetes and other risk factors for cardiovascular disease. Rosuvastatin is one of the most widely prescribed statins in the cardiovascular drugs market. It is available in both generic and branded forms, and is often prescribed in combination with other drugs to treat high cholesterol. It is generally well tolerated, with few side effects. The cardiovascular drugs market is a large and growing market, with many different drugs available to treat a variety of conditions. Rosuvastatin is one of the most popular drugs in this market, due to its effectiveness and safety profile. Some companies in the Rosuvastatin market include AstraZeneca, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more